Raphas Co., Ltd. (KOSDAQ:214260)
South Korea · Delayed Price · Currency is KRW 12,830
+140 (1.10%)
At close: Jan 23, 2026
Raphas Market Cap
Raphas has a market cap or net worth of 107.88 billion as of January 23, 2026. Its market cap has decreased by -16.63% in one year.
Market Cap
107.88B
Enterprise Value
124.41B
Revenue
32.16B
Ranking
n/a
PE Ratio
169.70
Stock Price
12,830.00
Market Cap Chart
Since November 11, 2019, Raphas's market cap has decreased from 147.86B to 107.88B, a decrease of -27.04%. That is a compound annual growth rate of -4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 107.88B | -2.06% |
| Dec 30, 2025 | 110.15B | -11.90% |
| Dec 30, 2024 | 125.03B | -24.40% |
| Dec 28, 2023 | 165.39B | 23.01% |
| Dec 29, 2022 | 134.46B | -64.88% |
| Dec 30, 2021 | 382.88B | 87.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Englewood Lab | 234.44B |
| Manyo Factory | 233.79B |
| CLIO Cosmetics Co.,Ltd | 230.27B |
| Genic | 149.92B |
| Aromatica | 118.25B |
| Icure Pharmaceutical Incorporation | 81.09B |
| Coreana Cosmetics | 67.04B |
| TS Trillion | 66.08B |